- Tabernero, J., Velez, L., Trevino, T. L., Grothey, A., Yaeger, R., Van Cutsem, E., . . . Kopetz, S. (2021). Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: Insights from the BEACON CRC study. ESMO Open, 6(6). https://doi.org/10.1016/j.esmoop.2021.100328 (Revisió)
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: Insights from the BEACON CRC study
on 24 de gener de 2022
with No hi ha comentaris
Deixa un comentari